专利号:US-5424432-A 优先权日:1994-05-26 标题:Process for the preparation of imidazolutidine 发明人:FREDENBURGH LAURA E; LARSEN ROBERT D; LIU JI; REAMER ROBERT A; SENANAYAKE CHRIS H; VERHOEVEN THOMAS R 权利人:MERCK & CO INC 摘要:This invention relates to a method for the preparation of a compound of formula I: I a key intermediate in the synthesis of a series of Angiotensin II receptor antagonists. The invention also relates to a selective reagent for conducting the Hofmann rearrangement, particularly in the formation of a pyridinoimidazolone, which is a percursor to the formation of an imidazopyfidine of formula I. This invention also relates to a method for the preparation of imidazolutidine, a key intermediate in the synthesis of 3-(2'-(N-benzoyl)sulfonamidobiphen-4-yl)-methyl-5,7 -dimethyl-2-ethyl-3H-imidazo[4,5-b]pyridine, using pyridinoimidazolone, an unreactive urea.
专利号:US-2023266302-A1 优先权日:2020-07-24 标 题:Synthesis and use of n-benzyl sulfonamides 发明人:LAMAR ANGUS A; SHEAFF ROBERT J 权利人:THE UNIV OF TULSA 摘要:Disclosed is a method for preparing N-benzyl sulfonamides. Also disclosed is a composition for treating cancer. The composition includes a N-benzyl sulfonamide and a metabolic inhibitor. Also disclosed is a method for determining the impact on cell ATP levels of a composition containing a N-benzyl sulfonamide with or without a metabolic inhibitor.
专利号:EP-1789107-B1 优先权日:2004-08-30 标题 :Medical stent provided with inhibitors of atp synthesis 发明人:POPOWSKI YOURI 权利人:INTERSTITIAL THERAPEUTICS 摘要:The present invention relates to a stent provided with a composition comprising at least one type of inhibitor of ATP synthesis optionally together with at least one inhibitor of the pentose phosphate pathway (PPP) for use in treating stenosis and preventing restenosis in vascular ducts, and for use in treating cancerous tumours present in ducts, resectioned cavities and scars, and for use in treating any disorder arising from the proliferation of cells in ducts or cavities.
专利号:US-6506572-B2 优先权日:1999-02-26 标题 :Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy 发明人:BIEDERMANN ELFI; EISENBURGER ROLF; HASMANN MAX; LOESER ROLAND; RATTEL BENNO; REITER FRIEDEMANN; SCHEIN BARBARA; SCHEMAINDA ISABEL; SCHULZ MICHAEL; SEIBEL KLAUS; VOGT KLAUS; WOSIKOWSKI KATJA 权利人:KLINGE CO CHEM PHARM FAB 摘要:New biologically active compounds are described which inhibit the cellular formation of niacinamide mononucleotide, and essential intermediate of the NAD(P) biosynthesis in the cell. These compounds can represent the active ingredient of a pharmaceutical composition for the treatment of cancers, leukaemias or for immunosuppression. Furthermore, screening methods are described as a tool for detecting the above active compounds, and for examination of a given cell type for its dependency on niacinamide as a precursor for NAD synthesis.
专利号:US-6531470-B1 优先权日:1998-01-23 标题:Oxazolidinone combinatorial libraries, compositions and methods of preparation 发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC 权利人:UPJOHN CO 摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.
专利号:US-6562844-B2 优先权日:1998-01-23 标 题:Oxazolidinone combinatorial libraries, compositions and methods of preparation 发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC 权利人:UPJOHN CO 摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.
[参考文献]: Almugadam Sh, Et Al. Influence Of 6-Aminonicotinamide (6An) On Leishmania Promastigotes Evaluated By Metabolomics: Beyond The Pentose Phosphate Pathway. Chem Biol Interact. 2018;294:167-177. [参考文献]: Cheng J, Et Al. Trim21 And Phlda3 Negatively Regulate The Crosstalk Between The Pi3K/akt Pathway And Ppp Metabolism. Nat Commun. 2020;11(1):1880. Published 2020 Apr 20. [参考文献]: Koutcher Ja, Et Al. Effect Of 6-Aminonicotinamide On The Pentose Phosphate Pathway: 31P Nmr And Tumor Growth Delay Studies. Magn Reson Med. 1996;36(6):887-892. [参考文献]: Tsouko E, Et Al. Regulation Of The Pentose Phosphate Pathway By An Androgen Receptor-Mtor-Mediated Mechanism And Its Role In Prostate Cancer Cell Growth. Oncogenesis. 2014;3(5):E103. Published 2014 May 26. [参考文献]: Ayan K Ghosh, Et Al. Metabolic Reconfiguration Of The Central Glucose Metabolism: A Crucial Strategy Of Leishmania Donovani For Its Survival During Oxidative Stress. Faseb J. 2015 May;29(5):2081-98.
合成参考文献
参考文献:10.1007/s00775-011-0817-4 摘要:West AK, Leung JYK, Chung RS. Neuroprotection and regeneration by extracellular metallothionein via lipoprotein-receptor-related proteins. JBIC Journal of Biological Inorganic Chemistry. 2011 Jul 21;16(7):1115. doi: 10.1007/s00775-011-0817-4.